Essayer OR - Gratuit
Why Cyber-resilience is Crucial
BioSpectrum Asia
|October 2024
In recent years, ransomware attacks have become more regular, stealthy, and expensive. They have also been developing swiftly.
-
Even for those lacking experience, new ransomware-as-a-service (RaaS) models provide pre-made avenues for financial gain for would-be threat actors. Attackers are also reinventing traditional strategies at the same time. Some are combining data theft and encryption into double extortion, increasing the strain on their victims. Some have invented "encryption-less" attacks, concentrating only on the possibility of a leak. Traditional ways of decrypting and recovering files are becoming less practical as new techniques develop.
Over $1.1 billion - that's how much ransomware gangs raked in last year, according to blockchain analyst Chainalysis. Does this astronomical figure say more about the sophistication of the adversary, or is it an indictment of our overall resilience to cyberattacks? Realistically, it’s a bit of both.
The healthcare sector exemplifies this reality. While healthcare facilities must continually ramp up cybersecurity efforts , the high value of personal health information (PHI) has made them an attractive target for cyber attackers. According to the Singapore Ministry of Health, PHI is 50 times more valuable on the black market than financial data because of its immutable nature, as it follows one throughout their lifespan, and can be exploited for identity theft to make fraudulent insurance claims or gain illegal access to prescriptions; among other nefarious purposes.
Cette histoire est tirée de l'édition October 2024 de BioSpectrum Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE BioSpectrum Asia
BioSpectrum Asia
Malaysia, Thailand implement medical device reliance programme after successful pilot
The Medical Device Authority (MDA) of Malaysia and the Thai Food and Drug Administration (Thai FDA) signed a Confidentiality Agreement to deepen regulatory cooperation and officially launched a 3-month pilot of the Medical Device Regulatory Reliance Programme as part of the agreement.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Strand Life Sciences launches South Asia's first Olink Explore HT Proteomics Service
India-based Strand Life Sciences, a subsidiary of Reliance Industries Limited, has announced the launch of its advanced proteomics capabilities powered by Olink Explore HT, marking a key milestone in expanding largescale multi-omics research in South Asia.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
UK transforms mental healthcare with new strategy
Frontline workers, clinicians and mental health experts are being invited to share their views on how to transform mental healthcare for children and adults in England, as the government launches a call for evidence to shape its once-in-a-generation crossgovernment mental health strategy.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Australia Budget 2026-27: Investing in Care, Health and Innovation.
The Australian Federal Budget 2026-27, presented by the Albanese Government, places strong emphasis on healthcare, aged care, T disability services, research, innovation and social equality.
4 mins
BioSpectrum Asia June 2026
BioSpectrum Asia
Gavi proposes new incentives for advancing vaccine manufacturing in Africa
With Gavi's African Vaccine Manufacturing Accelerator (AVMA) expected to make its first cash disbursement to an African vaccine manufacturer in the second half of 2026, Gavi, the Vaccine Alliance has proposed further measures totaling $189 million of additional investment to further aid development of Africa's vaccine manufacturing sector.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
New WHO online course strengthens good practices in clinical trials
High-quality clinical trials are essential for generating reliable evidence to inform health policy, clinical practice and public trust in science.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
World Bank approves $225 M to improve healthcare in Côte d'Ivoire
The World Bank has approved $225 million in financing to help Côte d'Ivoire improve the delivery of quality health, nutrition, and early childhood development services for millions of people, particularly for women, children, and vulnerable households.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Josh Xiao as CSO
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea lays focus on stabilising medical product supply
The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases
Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.
1 min
BioSpectrum Asia June 2026
Listen
Translate
Change font size
